Pinealon — Khavinson tripeptide bioregulator — brain / neuroprotective
Pinealon (Glu-Asp-Arg) is a tripeptide targeting brain tissue. Proposed to enter neurons and activate tissue-specific neuroprotective gene expression programs. In the TBI clinical study (n=72), improved memory, attention, and EEG bioelectric activity. Animal studies show reduced caspase-3 activity, normalized NMDA receptor expression, and protection from oxidative stress. Crosses the blood-brain barrier due to its small size.
نظرة عامة
هذه الصفحة جزء من مكتبة المركّبات المُصنَّفة بالأدلة في Hormonaly. جميع الادعاءات السريرية مرتبطة بمصادر علمية مُحكَّمة عبر خط أنابيب التحقق المزدوج للاستشهادات.
فئة المركّب
Khavinson tripeptide bioregulator — brain / neuroprotective
آلية العمل
Pinealon (Glu-Asp-Arg) is a tripeptide targeting brain tissue. Proposed to enter neurons and activate tissue-specific neuroprotective gene expression programs. In the TBI clinical study (n=72), improved memory, attention, and EEG bioelectric activity. Animal studies show reduced caspase-3 activity, normalized NMDA receptor expression, and protection from oxidative stress. Crosses the blood-brain barrier due to its small size.
الوضع التنظيمي
Not FDA approved. Available as research peptide. Not approved as pharmaceutical in Russia either (supplement/research status).
مستوى الأدلة
Low-Moderate — Clinical study n=72 TBI patients (improved cognition); preclinical animal data; primarily Khavinson group publications.